Bovie Medical Co. (NYSE:BVX) shares shot up 3% on Monday . The stock traded as high as $4.50 and last traded at $4.43, with a volume of 115,843 shares traded. The stock had previously closed at $4.30.

Several research firms have recently weighed in on BVX. JMP Securities reaffirmed an “outperform” rating and issued a $5.00 price target on shares of Bovie Medical in a report on Wednesday, August 3rd. Zacks Investment Research raised shares of Bovie Medical from a “sell” rating to a “hold” rating in a report on Tuesday, July 19th.

The stock’s market cap is $121.73 million. The company’s 50-day moving average price is $2.67 and its 200-day moving average price is $2.01.

In other news, insider John J. Mccarthy III bought 90,750 shares of the stock in a transaction that occurred on Wednesday, August 17th. The shares were bought at an average price of $3.30 per share, for a total transaction of $299,475.00. Following the purchase, the insider now owns 115,750 shares in the company, valued at $381,975. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.